Key mechanisms such as (a) inflammatory adipokine signaling from visceral fat, (b) hepatic insulin resistance and ectopic lipid accumulation, (c) gut microbiota alterations and endotoxemia, (d) impaired glucose uptake in skeletal muscle, and (e) pancreatic β-cell dysfunction remain central to the disease. This evidence concerns the gene INS and serum lipopolysaccharide activity.